|
|
???tair.name??? >
???browser.page.title.author???
|
"ym liu"???jsp.browse.items-by-author.description???
Showing items 1-9 of 9 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立高雄第一科技大學 |
2015.11 |
Low-voltage and wide-band tuning of lasing in a dye-doped liquid-crystal sandwich structure.
|
YS, Lo;YM, Liu;HC, Yeh |
| 臺北醫學大學 |
2014 |
Indole-3-ethylsulfamoylphenylacrylamides: Potent histone deacetylase inhibitors with anti-inflammatory activity
|
Mehndiratta, S;YL, Hsieh;YM, Liu;AW, Wang;HY, Lee;LY, Liang;Kumar, S;CM, Teng;CR*, Yang;JP*, Liou |
| 臺北醫學大學 |
2014 |
Tubulin inhibitors: a patent review
|
YM, Liu;HL, Chen;HY, Lee;JP, Liou |
| 臺北醫學大學 |
2014 |
Azaindolylsulfonamides, with a More Selective Inhibitory Effect on Histone Deacetylase 6 Activity, Exhibit Antitumor Activity in Colorectal Cancer HCT116 Cells
|
HY, Lee;AC, Tsai;MC, Chen;PJ, Shen;YC, Cheng;CC, Kuo;SL, Pan;YM, Liu;JF, Liu;TK, Yeh;JC, Wang;CY, Chang;JY, Chang;JP, Liou |
| 臺北醫學大學 |
2014 |
A novel class I HDAC inhibitor, MPT0G030, induces cell apoptosis and differentiation in human colorectal cancer cells via HDAC1/PKCδ and E-cadherin
|
LT, Wang;JP, Liou;YH, Li;YM, Liu;SL, Pan;CM, Teng |
| 臺北醫學大學 |
2013 |
Individual risk prediction model for incident cardiovascular disease: A Bayesian clinical reasoning approach
|
YM, Liu;SL, Chen;AM, Yen;HH, Chen |
| 臺北醫學大學 |
2013 |
1-Arylsulfonyl-5-(N-hydroxyacrylamide)indolines Histone Deacetylase Inhibitors Are Potent Cytokine Release Suppressors
|
HY, Lee;CR, Yang;MJ, Lai;HL, Huang;YL, Hsieh;YM, Liu;YH, Yeh TK. Li;Mehndiratta, S;CM, Teng;JP*, Liou |
| 臺北醫學大學 |
2013 |
Furanylazaindoles: Potent Anticancer Agents in Vitro and in Vivo
|
HY, Lee;SL, Pan;MC, Su;YM, Liu;CC, Kuo;YT, Chang;JS, Wu;CY, Nien;Mehndiratta, S;CY, Chang;SY, Wu;MJ, Lai;JY*, Chang;JP*, Liou |
| 臺北醫學大學 |
2012 |
Individual risk prediction model for incident cardiovascular disease: A Bayesian clinical reasoning approach
|
YM, Liu;SL, Chen;AM, Yen;HH, Chen |
Showing items 1-9 of 9 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
